Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 622356
                    [Title] => Novartis anti-malaria program, drug cited
                    [Summary] => 
The groundbreaking medicine access program and innovative malaria treatment of research-based Swiss healthcare company Novartis recently received two prestigious awards.
                    [DatePublished] => 2010-10-21 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

INTERNATIONAL BUSINESS LEADERS FORUM

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 622356
                    [Title] => Novartis anti-malaria program, drug cited
                    [Summary] => 
The groundbreaking medicine access program and innovative malaria treatment of research-based Swiss healthcare company Novartis recently received two prestigious awards.
                    [DatePublished] => 2010-10-21 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Novartis anti-malaria program, drug cited

October 21, 2010 - 12:00am

The groundbreaking medicine access program and innovative malaria treatment of research-based Swiss healthcare company Novartis recently received two prestigious awards.

Science and Environment